782479-05-4

Basic information

• Product Name: Cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxylic acid, 2-[[(4-broMophenyl)sulfonyl]oxy]-6-[[(cyclopentyloxy)carbonyl]aMino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-5,16-dioxo-, Methyl ester, (2S,6S,12Z,13aS,14aR,16aS)-
• Synonyms: Cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxylic acid, 2-[[(4-broMophenyl)sulfonyl]oxy]-6-[[(cyclopentyloxy)carbonyl]aMino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-5,16-dioxo-, Methyl ester, (2S,6S,12Z,13aS,14aR,16aS)-;(2S,6S,12Z,13aS,14aR,16aS)-2-[[(4-Bromophenyl)sulfonyl]oxy]-6-[[(cyclopentyloxy)carbonyl]amino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-5,16-dioxo-cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxylic acid methyl ester
• CAS NO: 782479-05-4
• Molecular Formula: C31H40BrN3O9S
• Molecular Weight: 711
• Mol File: 782479-05-4.mol
• Article Data: 4

Chemical Properties

• Density: 1.49±0.1 g/cm3 (20 ºC 760 Torr)
• CAS DataBase Reference: Cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxylic acid, 2-[[(4-broMophenyl)sulfonyl]oxy]-6-[[(cyclopentyloxy)carbonyl]aMino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-5,16-dioxo-, Methyl ester, (2S,6S,12Z,13aS,14aR,16aS)-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxylic acid, 2-[[(4-broMophenyl)sulfonyl]oxy]-6-[[(cyclopentyloxy)carbonyl]aMino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-5,16-dioxo-, Methyl ester, (2S,6S,12Z,13aS,14aR,16aS)-(782479-05-4)
• EPA Substance Registry System: Cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxylic acid, 2-[[(4-broMophenyl)sulfonyl]oxy]-6-[[(cyclopentyloxy)carbonyl]aMino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-5,16-dioxo-, Methyl ester, (2S,6S,12Z,13aS,14aR,16aS)-(782479-05-4)

Safety Data

• Hazardous Substances Data: 782479-05-4(Hazardous Substances Data)

Upstream product

• 572922-89-5 (2S,4R)-4-hydroxy-2-[(1R,2S)-1-methoxycarbonyl-2-vinylcyclopropylcarbamoyl]pyrrolidine-1-carboxylic acid tert-butyl ester 
• 13726-69-7 (2S,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid 
• 87250-97-3 2’-methyl-2’-propanyl (1S,4S)-3-oxo-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate 
• 912291-94-2 4-nitro-benzoic acid 1-(2-cyclopentyloxycarbonylamino-non-8-enoyl)-5-(1-methoxycarbonyl-2-vinylcyclopropylcarbamoyl)-pyrrolidin-3-yl ester 
• 912291-95-3 (1S,4R,6S,7Z,14S,18S)-14-cyclopentyloxycarbonylamino-18-(4-nitro-benzoyloxy)-2,15-dioxo-3,16-diaza-tricyclo[14.3.0.0^4,6]nonadec-7-ene-4-carboxylic acid methyl ester 
• 769167-57-9 (1S,2R)-1-{[(2S,4S)-1-((S)-2-cyclopentyloxycarbonylamino-oct-7-enoyl)-4-hydroxypyrrolidine-2-carbonyl]-amino}-2-vinyl-cyclopropanecarboxylic acid methyl ester 
• 769167-55-7 (S)-2-cyclopentyloxycarbonyl-amino-8-nonenoic acid 
• 202477-59-6 (2S,4R)-1-(tert-butoxycarbonyl)-4-[(methylsulfonyl)oxy]-2-pyrrolidinecarboxylic acid 
• 862273-27-6 (1R,2S)-1-amino-2-vinylcyclopropane carboxylic acid methyl ester tosylate salt 
• 98-58-8 4-bromobenzenesulfonyl chloride 
• 912291-96-4 (1S,4R,6S,7Z,14S,18S)-14-cyclopentyloxycarbonylamino-18-hydroxy-2,15-dioxo-3,16-diaza-tricyclo[14.3.0.0^4,6]nonadec-7-ene-4-carboxylic acid methyl ester 
• 769167-58-0 (1S,2R)-1-{[(2S,4S)-4-(4-bromo-benzenesulfonyloxy)-1-((S)-2-cyclopentyloxycarbonylamino-oct-7-enoyl)pyrrolidine-2-carbonyl]-amino}-2-vinylcyclopropanecarboxylic acid methyl ester 
• 572922-90-8 (2S,4S)-2-((1R,2S)-1-Methoxycarbonyl-2-vinyl-cyclopropylcarbamoyl)-4-(4-nitro-benzoyloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 769167-54-6 [(S)-1-((1S,4S)-3-Oxo-2-oxa-5-aza-bicyclo[2.2.1]heptane-5-carbonyl)-oct-7-enyl]-carbamic acid cyclopentyl ester 

Downstream Products

• 300832-84-2 ciluprevir 

Relevant articles and documents

New air-stable ruthenium olefin metathesis precatalysts derived from bisphenol S

Synthesis and screening of catalytic activity of novel mono- and diruthenium carbene complexes 7a and 7b prepared from inexpensive Bisphenol S via Claisen rearrangement-isomerisation route is described. These catalysts constitute an excellent tool for rin

Olefin ring-closing metathesis as a powerful tool in drug discovery and development - potent macrocyclic inhibitors of the hepatitis C virus NS3 protease

Peptidomimetic inhibitors of the hepatitis C NS3 protease often exhibit poor biopharmaceutical properties. Structure modification of a substrate-based tripeptide into a β-strand 15-membered ring scaffold provided a new class of peptidomimetics that are si